-
The Scope Of Scrutiny
Jan 11, 2019, 12:15 PM by Michael CroftFull storyBio-IT World Contributed Commentary | As biotechnology, pharmaceutical, and medical device companies pursue treatment innovations to improve patient outcomes across diagnoses, many miss a significant step that has been fundamental in financial services and insurance: financial compliance risk management.
-
23andMe Will Add Weight-Loss Advice To Its DNA-Testing Services
Jan 9, 2019, 15:17 PM by Michael CroftBloomberg | Consumer DNA-testing giant 23andMe plans to add new wellness offerings it hopes will help its customers shed a few pounds, but some genetics experts say the jury is still out on the science behind the products.Full story -
Igneous Brings Structure To Unstructured Data With As-A-Service Solution
Jan 9, 2019, 07:40 AM by Michael CroftFull storyBio-IT World | Igneous is offering its cloud-native solution to data-centric organizations in order to both monitor large amounts of data and prevent silos within the clinical research space.
-
Sekisui XenoTech Expands Partnership for Japanese Collection of Research Bioresources Cell Bank (JCRB) Distribution
Jan 8, 2019, 09:22 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Jan 8, 2019 - After 3 years as the official distributor of JCRB cell lines in North America, Sekisui XenoTech has expanded its agreement with the National Institute of Biomedical Innovation to include distribution to EuropeFull story -
Creative Diagnostics Introduces Pathology Antibodies for Researchers
Jan 7, 2019, 22:56 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Jan 8, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now is proud to announce that it launches a number of high quality pathology antibodies including Her2, PD-1, Ki-67, Tim3, CTLA4, Lp-PLA2, Muc2, Cytokeratin 18, BRAF V600E, IDH1 R132H, MLH1, MSH2, MSH6, and PMS2Full story -
Eli Lilly Makes An $8B Cancer Genetics Bet With Loxo Acquisition
Jan 7, 2019, 10:09 AM by Michael CroftXconomy | Eli Lilly is set to acquire Loxo Oncology for approximately $8 billion---a deal that brings to the Indianapolis pharmaceutical giant a class of drugs that treat cancers with particular genetic signatures.Full story -
10x Genomics Announces $35m Funding
Jan 7, 2019, 08:05 AM by Michael CroftFull storyBio-IT World News Brief | On day one of the JP Morgan Healthcare Conference, 10x Genomics announces $35 million in funding as an extension of its Series D financing.
-
Creative Proteomics Upgrades Four Proteomics Services for Protein Related Projects
Jan 3, 2019, 22:55 PM by Michael CroftSHIRLEY, NY - Jan 5, 2019 - Creative Proteomics, a leading supplier in drug development services, recently announces that they have upgraded four services related to protein research projectsFull story -
Bristol-Myers Squibb Will Acquire Celgene In Blockbuster $74B Deal
Jan 3, 2019, 09:44 AM by Michael CroftSTAT | The transaction between biopharma giants joins two of the largest companies in oncology, both of which have been facing setbacks.Full story -
Top 10 Stories Of 2018: Data Science, Five Use Cases For AI And Machine Learning, And More
Jan 2, 2019, 11:45 AM by Michael CroftFull storyBio-IT World | As we head into 2019, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2018.
-
Poll Americans Support Gene-Editing Embryos To Prevent Diseases
Dec 28, 2018, 12:53 PM by Michael CroftSTAT | Most Americans say it would be OK to use gene-editing technology to create babies protected against a variety of diseases - but a new poll shows they'd draw the line at changing DNA so children are born smarter, faster or taller.Full story -
AI In The Clinic: What AI Will Look Like For Healthcare
Dec 21, 2018, 13:00 PM by Michael CroftBio-IT World | Artificial Intelligence will have as transformational an impact as the internet did, predicts Jay Bellissimo, managing partner at IBM services. Every company needs an AI strategy, he says, and it is not a problem only for IT. Data creates insight, and insight creates knowledge. Mining the 80% of the data that’s not searchable via the internet is your company’s data advantage.Full story -
PetaGene Announces $2.1M To Further Genomic Compression
Dec 20, 2018, 10:05 AM by Michael CroftBio-IT World News Brief PetaGene, a two-time winner of Bio-IT World’s Best of Show award for product excellence, has announced $2.1 million in new funding.Full story -
Biogen, DDN, Qlucore, And More: News From December 2018
Dec 19, 2018, 10:00 AM by Michael CroftBio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Biogen, DDN, Qlucore, and more.Full story -
Certara Publishes New Report Investigating Success Factors for Outcomes-based Contracting, Giving Guidelines to Pharma and Payers
Dec 19, 2018, 08:14 AM by Michael CroftPRINCETON, NJ - Dec 19, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced a new research report that investigates the potential of pharmaceutical outcomes-based contractingFull story -
CD Genomics Claims a Discount for Most Services to Celebrate Christmas&New Year
Dec 18, 2018, 22:59 PM by Michael CroftSHIRLEY, NY - Dec 19, 2018 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the launch of Christmas and New Year promotion from December 1st to January 31stFull story -
Vyasa Analytics Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research
Dec 18, 2018, 15:43 PM by Michael CroftBOSTON, MA - Dec 18, 2018 - Vyasa Analytics, a provider of scalable, deep-learning software and analytics for life sciences and healthcare organizations, today announced they have joined Accentures partner ecosystem, designed to help independent software vendors (ISVs) and life science companies work more effectively to accelerate drug discovery efforts and improve patient outcomesFull story -
Creative Biolabs Announced the Monoclonal Antibody Screening Technology for Research Use
Dec 18, 2018, 00:33 AM by Michael CroftSHIRLEY, NY - Dec 18, 2018 - December 18, 2018, Creative Biolabs, one of world-leading suppliers and manufacturers from USA, announced a technique about the monoclonal antibody screening for research useFull story -
Oak Ridge Tackles Opioids With Assistance From World’s Fastest Supercomputer
Dec 14, 2018, 08:05 AM by Michael CroftFull storyBio-IT World | The US Department of Energy’s Oak Ridge National Laboratory is tackling the opioid crisis by using the world’s fastest supercomputer. With the help of IBM’s recently launched Summit supercomputer, the Oak Ridge team was able to analyze 85 million genetic markers and understand complex, epistatic genetic architectures responsible for challenging traits in phenotype.
-
Allen Institute Announces New Division Dedicated To Studying Human Immune System
Dec 13, 2018, 10:20 AM by Michael CroftFull storyBio-IT World | The Allen Institute announced a new division, the Allen Institute for Immunology, which will be dedicated to studying the human immune system.